ATAZANAVIR

Product NDC
59762-0410
11-digit product format
597620410
Labeler code
59762
Product ID
59762-0410_0a23818b-ca89-4987-a101-2a0d1494d007
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
ATAZANAVIR
Dosage form
CAPSULE, GELATIN COATED
Route
ORAL
Labeler
Greenstone LLC
Application
NDA021567
Marketing category
NDA AUTHORIZED GENERIC
Marketing start
2018-01-02
Marketing end
2019-12-31
Substance
ATAZANAVIR SULFATE
Active strength
300 mg/1
Pharmacologic classes
HIV Protease Inhibitors [MoA],Protease Inhibitor [EPC],UGT1A1 Inhibitors [MoA],UDP Glucuronosyltransferases Inhibitors [MoA],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 3A Inhibitors [MoA],Cytochrome P450 2C8 Inhibitors [MoA]
NDC exclude flag
No
Listing certified through
0000-00-00
Current FDA listing
Historical FDA.report record

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
59762-0410-3EA - Each59762-04104e7ae428-d29b-455f-861b-2d004eed55f412018-02-20